tiprankstipranks
Advertisement

CWI - ETF AI Analysis

Compare

Top Page

CWI

SPDR MSCI ACWI ex-US ETF (CWI)

Rating:59Neutral
Price Target:
CWI, the SPDR MSCI ACWI ex-US ETF, has a solid but not top-tier rating, mainly supported by high-quality global leaders like TSMC, Novartis, HSBC, and AstraZeneca, which show strong financial performance, positive earnings commentary, and good long-term growth positioning. However, holdings such as Alibaba and Tencent introduce some drag on the rating due to bearish technical trends and cash flow or expense challenges, and the fund’s meaningful exposure to a few large tech and pharma names adds concentration risk if those sectors face a downturn.
Positive Factors
Broad International Diversification
The ETF spreads its investments across many countries outside the U.S., which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across financials, industrials, technology, health care, and other sectors, limiting reliance on any one part of the economy.
Generally Strong Top Holdings Performance
Several of the largest positions, including major chipmakers and global health care companies, have shown strong gains so far this year, supporting the fund’s overall results.
Negative Factors
Moderate Concentration in Financials
With a large share of assets in financial stocks, the fund can be more sensitive to banking and interest-rate risks.
Exposure to Weak Chinese Tech Names
Some key Chinese technology holdings, such as Tencent, have shown weak recent performance, which can drag on returns.
Mixed Performance Among Top Holdings
A few notable positions, including Royal Bank of Canada and AstraZeneca, have been lagging, which offsets some of the strength from better-performing stocks.

CWI vs. SPDR S&P 500 ETF (SPY)

CWI Summary

CWI is an ETF that follows the MSCI All Country World ex USA Index, meaning it invests in stocks from many countries around the world but leaves out U.S. companies. It holds a wide mix of sectors like financials, technology, and industrials, and includes well-known names such as TSMC and Samsung Electronics. Investors might consider CWI to diversify beyond the U.S. and tap into growth in both developed and emerging markets. A key risk is that international stocks can be volatile and may rise or fall differently from the U.S. market.
How much will it cost me?The SPDR MSCI ACWI ex-US ETF (CWI) has an expense ratio of 0.3%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than the average for passively managed ETFs because it provides broad international exposure across developed and emerging markets, which can involve higher costs for tracking and managing the index.
What would affect this ETF?The SPDR MSCI ACWI ex-US ETF could benefit from global economic growth, particularly in emerging markets, and advancements in technology and healthcare sectors, which are among its top holdings. However, it may face challenges from geopolitical tensions, regulatory changes in key regions, or economic slowdowns in major markets outside the U.S. Additionally, fluctuations in currency exchange rates could impact returns for U.S.-based investors.

CWI Top 10 Holdings

CWI leans heavily on global tech, with chip giants TSMC and ASML acting as key engines: both have been rising over the past few months, even if they’ve hit a recent speed bump. Samsung has also added fuel to the fund’s semiconductor tilt with a strong run lately. On the flip side, Chinese heavyweights Tencent and Alibaba have been lagging, weighing on returns as sentiment toward China remains shaky. Rounding things out, steadier names like Shell and big European pharma help balance this globally diversified, ex-U.S. mix.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
TSMC3.96%$93.36M$1.43T100.40%
81
Outperform
Samsung Electronics1.75%$41.22M$706.68B184.03%
ASML Holding NV1.63%$38.43M€427.52B82.36%
76
Outperform
Tencent Holdings 1.15%$27.16MHK$4.38T-3.62%
75
Outperform
Shell (UK)0.93%$21.87M£201.24B27.67%
73
Outperform
HSBC Holdings0.92%$21.58M£209.91B39.26%
80
Outperform
Novartis AG0.89%$20.99MCHF220.64B22.80%
80
Outperform
Roche Holding AG0.88%$20.76M$315.49B12.61%
73
Outperform
AstraZeneca0.85%$19.96M$301.53B29.24%
80
Outperform
Royal Bank Of Canada0.82%$19.32M$225.81B42.35%
75
Outperform

CWI Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
37.84
Negative
100DMA
36.72
Negative
200DMA
34.97
Positive
Market Momentum
MACD
-0.60
Positive
RSI
47.04
Neutral
STOCH
34.41
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CWI, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 36.70, equal to the 50-day MA of 37.84, and equal to the 200-day MA of 34.97, indicating a neutral trend. The MACD of -0.60 indicates Positive momentum. The RSI at 47.04 is Neutral, neither overbought nor oversold. The STOCH value of 34.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CWI.

CWI Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.36B0.30%
59
Neutral
$8.26B0.07%
65
Neutral
$1.60B0.50%
61
Neutral
$1.47B0.54%
62
Neutral
$1.15B0.15%
62
Neutral
$1.02B0.85%
61
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CWI
SPDR MSCI ACWI ex-US ETF
36.59
7.82
27.18%
VIGI
Vanguard International Dividend Appreciation ETF
ILOW
AB International Low Volatility Equity ETF
CGIC
Capital Group International Core Equity ETF
IGRO
iShares International Dividend Growth ETF
WCMI
First Trust WCM International Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement